Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M38,106Revenue $M15,259Net Margin (%)14.8Z-Score0
Enterprise Value $M38,106EPS $3.7Operating Margin %16.7F-Score0
P/E(ttm))15.3Cash Flow Per Share $5.6Pre-tax Margin (%)15.1Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %7.8Quick Ratio0Cash flow > EarningsN
Price/Sales2.35-y EBITDA Growth Rate %8.0Current Ratio0Lower Leverage y-yN
Price/Cash Flow11.7y-y EBITDA Growth Rate %-18.4ROA % (ttm)11.7Higher Current Ratio y-yN
Dividend Yield %2.9Insider Buy (3m)0ROE % (ttm)35.7Less Shares Outstanding y-yN
Payout Ratio %60.0Shares Outstanding M542ROI % (ttm)15.1Gross Margin Increase y-yN

Gurus Latest Trades with BAX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAXDavid Dreman 2014-09-30 Buy 0.02%$71.28 - $77
($74.81)
$ 70.31-6%New holding, 3397 sh.3,397
BAXRay Dalio 2014-09-30 Add0.01%$71.28 - $77
($74.81)
$ 70.31-6%Add 220.37%18,463
BAXRobert Olstein 2014-09-30 Sold Out -0.59%$71.28 - $77
($74.81)
$ 70.31-6%Sold Out0
BAXJean-Marie Eveillard 2014-06-30 Add0.18%$71.98 - $75.45
($73.67)
$ 70.31-5%Add 90872.4%1,000,696
BAXJohn Keeley 2014-06-30 Buy 0.05%$71.98 - $75.45
($73.67)
$ 70.31-5%New holding, 37150 sh.37,150
BAXScott Black 2014-06-30 Reduce-0.43%$71.98 - $75.45
($73.67)
$ 70.31-5%Reduce -30.98%123,976
BAXVanguard Health Care Fund 2014-06-30 Sold Out -0.11%$71.98 - $75.45
($73.67)
$ 70.31-5%Sold Out0
BAXRay Dalio 2014-06-30 Reduce-0.03%$71.98 - $75.45
($73.67)
$ 70.31-5%Reduce -90.74%5,763
BAXJohn Hussman 2014-06-30 Reduce-0.02%$71.98 - $75.45
($73.67)
$ 70.31-5%Reduce -50%3,725
BAXDavid Dreman 2014-06-30 Sold Out -0.01%$71.98 - $75.45
($73.67)
$ 70.31-5%Sold Out0
BAXCharles Brandes 2014-03-31 Buy 0.19%$66.49 - $72.85
($68.75)
$ 70.312%New holding, 204560 sh.204,560
BAXScott Black 2014-03-31 Add0.17%$66.49 - $72.85
($68.75)
$ 70.312%Add 13.41%179,629
BAXDavid Dreman 2014-03-31 Buy 0.01%$66.49 - $72.85
($68.77)
$ 70.312%New holding, 2453 sh.2,453
BAXJean-Marie Eveillard 2014-03-31 Reduce$66.49 - $72.85
($68.77)
$ 70.312%Reduce -85.53%1,100
BAXChris Davis 2014-03-31 Sold Out $66.49 - $72.85
($68.77)
$ 70.312%Sold Out0
BAXJohn Hussman 2014-03-31 Reduce-0.49%$66.49 - $72.85
($68.75)
$ 70.312%Reduce -93.07%7,450
BAXVanguard Health Care Fund 2014-03-31 Reduce-0.41%$66.49 - $72.85
($68.75)
$ 70.312%Reduce -77.96%531,100
BAXRay Dalio 2014-03-31 Reduce-0.07%$66.49 - $72.85
($68.77)
$ 70.312%Reduce -67%62,263
BAXScott Black 2013-12-31 Add1.06%$63.89 - $69.47
($66.75)
$ 70.315%Add 776.11%158,392
BAXRobert Olstein 2013-12-31 Add0.15%$63.89 - $69.47
($66.75)
$ 70.315%Add 24.19%77,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BAX David Dreman 2014-09-303,39700.02New Buy
BAX Ray Dalio 2014-09-3018,46300.01+220.37%
BAX John Keeley 2014-09-3040,6500.010.06+9.42%
BAX Charles Brandes 2014-09-30225,0230.040.21+7.2%
BAX John Rogers 2014-09-3063,0510.010.06+2.94%
BAX Scott Black 2014-09-30124,3460.021.3+0.3%
BAX Bill Nygren 2014-09-301,623,0000.30.75
BAX Dodge & Cox 2014-09-303,38200
BAX John Hussman 2014-09-303,72500.02
BAX Jean-Marie Eveillard 2014-09-30997,0560.180.18-0.36%
BAX Tweedy Browne 2014-09-302,581,2770.484.3-0.42%
BAX Mario Gabelli 2014-09-30224,9400.040.09-7.58%
BAX Robert Olstein 2014-09-30000Sold Out
BAX Meridian Funds 2013-06-308,60000.02
Premium Most recent portfolio changes are included for Premium Members only!


BAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FORSYTH JOHN DDirector 2014-08-15Sell4,830$74.9-4.7view
Shapazian Carole JDirector 2014-07-25Sell1,645$76.98-7.27view
STALLKAMP THOMAS TDirector 2014-07-24Sell8,300$76.82-7.08view
HANTSON LUDWIGCorporate Vice President 2014-07-09Sell24,693$76-6.08view
STROUCKEN ALBERT P LDirector 2014-05-27Sell3,840$74.41-4.07view
Shapazian Carole JDirector 2014-05-02Sell5,680$75.28-5.18view
STROUCKEN ALBERT P LDirector 2014-04-24Buy696$67.525.72view
STORM KEES JDirector 2014-04-23Sell5,760$72.45-1.48view
Devitt Blake EDirector 2014-04-21Sell4,334$73.12-2.38view
Bufalino Sebastian JCorporate Vice President 2014-03-27Sell21,600$75.1-4.95view

Press Releases about BAX :

Quarterly/Annual Reports about BAX:

News about BAX:

Articles On GuruFocus.com
Expectations, Price, and Fundamentals (Or Congressional Questions Gone Awry) Jan 23 2015 
Pfizer Spreading Its Wings Into A New Domain Of Life Sciences Dec 09 2014 
I think Zimmer Will Outperform S&P 500 Performance Dec 04 2014 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 19 2014 
Medtronic Inc. (MDT) Dividend Stock Analysis Sep 12 2014 
Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
Abbott: A Brighter Future Aug 28 2014 
Diamond Hill Capital Comments on Baxter International Inc Jul 25 2014 
Why I Bought Baxter International Jun 19 2014 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis May 30 2014 


More From Other Websites
Baxter International (BAX) Earnings Report: Q4 2014 Conference Call Transcript Jan 29 2015
Baxter (BAX) Beats Q4 Earnings Estimates, Sales Up Y/Y - Analyst Blog Jan 29 2015
Baxter's (BAX) Q4 Earnings and Revenues Beat Estimates - Tale of the Tape Jan 29 2015
Baxter International Inc Earnings Call scheduled for 8:30 am ET today Jan 29 2015
Baxter Offers Disappointing Outlook Jan 29 2015
Baxter beats Street 4Q forecasts Jan 29 2015
Baxter beats Street 4Q forecasts Jan 29 2015
BAXTER INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 29 2015
Q4 2014 Baxter International Inc Earnings Release - Before Market Open Jan 29 2015
Baxter’s Fourth Quarter Financial Results Exceed Expectations Jan 29 2015
Baxter’s Fourth Quarter Financial Results Exceed Expectations Jan 29 2015
Up to Speed: Peltz receives ammo in fight against DuPont (Video) Jan 28 2015
Will Baxter International (BAX) Disappoint Earnings in Q4? - Analyst Blog Jan 27 2015
Pfizer's Prevenar 13 Wins CHMP Backing for Expanded Use - Analyst Blog Jan 26 2015
CareFusion Banks on Pipeline Strength, Pricing Woes Remain - Analyst Blog Jan 26 2015
Merrimack Reveals Additional Data from Oncology Candidate - Analyst Blog Jan 22 2015
Baxter's (BAX) PHOXILLUM Solutions Get FDA Nod for CRRT - Analyst Blog Jan 21 2015
Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous... Jan 20 2015
Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous... Jan 20 2015
Merrimack Pharmaceuticals Presents Additional Analyses of Phase 3 MM-398 NAPOLI-1 Study at the... Jan 20 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Sww
ReplySww - 7 months ago
Bax medical devices revenue ~9b, bio science ~7b
using 3X sales of medical devices company and 4X for drugs company, 27b+28b = 55b market cap,as of June 2014, BAX market cap is 39b, so it can sell for

72 * (1 + 16/39) = 99

72 is current stock price, with an upside of around 35%

so my guess is BAX may be able to sell for around 90 after spin-off.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK